Sign in
4

Changes in Ownership

Royalty Pharma plc Filed Acc 0001802768-23-000032

EVP, Investments & CLO acquired 150,000 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Lloyd George W. EVP, Investments & CLO 2023-11-13 Conversion +50,000 80,000 I: show line 1 in the form
Lloyd George W. EVP, Investments & CLO 2023-11-13 Conversion +100,000 220,000 I: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Lloyd George W. EVP, Investments & CLO 2023-11-13 Conversion · LP interests in RPI US Partners 2019, LP −5,000 245,299 I: show line 3 in the form
Lloyd George W. EVP, Investments & CLO 2023-11-13 Conversion · LP interests in RPI US Partners 2019, LP −10,000 162,680 I: show line 4 in the form
Loading xslF345X05/wk-form4_1700008499.xml…